Clinical Features of HPV-Related Head and Neck Squamous Cell Carcinoma: Presentation and Work-Up

Otolaryngologic Clinics of North America

Volumn 45, Issue 4, 2012, Pages 779-793

  Koch, Wayne M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cystic nodal metastasis; Palatine and lingual tonsils; Unknown primary

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER GRADING; CANCER LOCALIZATION; CANCER STAGING; CERVICAL LYMPH NODE; CHEMORADIOTHERAPY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HIGH RISK PATIENT; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; OROPHARYNX; PALATINE TONSIL; PALPATION; POSITRON EMISSION TOMOGRAPHY; REVIEW; SECOND CANCER; SMOKING; SYMPTOM; TOBACCO; TONGUE; TONSILLECTOMY; TREATMENT OUTCOME; ULTRASOUND; UPPER GASTROINTESTINAL TRACT; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 84863871443     PISSN: 00306665     EISSN: 15578259     Source Type: Journal    
DOI: 10.1016/j.otc.2012.04.004     Document Type: Review

References (13)

1. Gillison M.L., Koch W.M., Capone R.B., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92(9):709-720.
2. Maxwell J.H., Kumar B., Feng F.Y., et al. Bradford CR. HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans. Head Neck 2010, 32(5):562-567.
3. Singhi A.D., Califano J., Westra W.H. High-risk human papillomavirus in nasopharyngeal carcinoma. Head Neck 2012, 34(2):213-218.
4. Westra W.H. The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol 2009, 3(1):78-81.
5. Slaughter D.P., Southwick H.W., Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953, 6(5):963-968.
6. Ho T., Zahurek M., Koch W.M. Prognostic significance of presentation-to-diagnosis interval in patients with oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2004, 130:45-51.
7. Goldenberg D., Begum S., Westra W.H., et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 2008, 30(7):898-903.
8. D'Souza G., Kreimer A.R., Viscidi R., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007, 356(19):1944-1956.
9. Schrank T.P., Han Y., Weiss H., et al. Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States-possible role for human papillomavirus in survival disparities. Head Neck 2011, 33(1):45-53.
10. McQuone S.J., Eisele D.W., Lee D.J., et al. Occult tonsillar carcinoma in the unknown primary. Laryngoscope 1998, 108:1605-1610.
11. Koch W.M., Bhatti N., Williams M.F., et al. Oncologic rationale for bilateral tonsillectomy for head and neck squamous cell carcinoma of an unknown primary source. Otolaryngol Head Neck Surg 2001, 124:331-333.
12. Wartski M., Le Stanc E., Gontier E., et al. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT. Nucl Med Commun 2007, 28(5):365-371.
13. Silva P., Hulse P., Sykes A.J., et al. Should FDG-PET scanning be routinely used for patients with an unknown head and neck squamous primary?. J Laryngol Otol 2007, 121(2):149-153.